Our study of men with LP/P BRCA1/2 variants, followed by a yearly PSA screening program, indicated a higher than expected number of men with prostate cancer in the early stages at a young age but also observed poor oncological outcomes. This evidence concerns the gene KLK3 and prostate cancer.